Century Link Investment Management CO Biogen Inc. Transaction History

Century Link Investment Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 09, 2020	SELL	$258.66 - $342.55 $1.02 Million - $1.35 Million	-3,941 Closed	0 $0
Q4 2019 Jan 13, 2020	SELL	$220.06 - $304.07 $135,116 - $186,698	-614 Reduced 13.48%	3,941 $1.17 Million
Q3 2019 Oct 15, 2019	SELL	$217.44 - $243.88 $167,646 - $188,031	-771 Reduced 14.48%	4,555 $1.06 Million
Q1 2019 Apr 04, 2019	SELL	$216.71 - $338.96 $22,971 - $35,929	-106 Reduced 1.95%	5,326 $1.26 Million
Q4 2018 Jan 04, 2019	SELL	$278.5 - $352.75 $138,136 - $174,964	-496 Reduced 8.37%	5,432 $1.64 Million
Q3 2018 Oct 09, 2018	SELL	$293.51 - $383.83 $208,098 - $272,135	-709 Reduced 10.68%	5,928 $2.09 Million
Q2 2018 Jul 05, 2018	BUY	$257.52 - $306.91 $402,503 - $479,700	1,563 Added 30.8%	6,637 $1.93 Million
Q4 2017 Jan 08, 2018	SELL	$307.64 - $344.58 $167,971 - $188,140	-546 Reduced 9.72%	5,074 $1.62 Million
Q3 2017 Oct 06, 2017	BUY	$281.15 - $329.69 $1.58 Million - $1.85 Million	5,620	5,620 $1.76 Million

998

130M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Century Link Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Century Link Investment Management CO with notifications on news.